Please NOTE: Grant programs for 2020 funding will be offered in one of three cycles with RFAs going live in September 2019, November 2019 or May 2020. Grant programs for 2021 funding will be offered in two cycles with RFAs going live in November 2020 or May 2021.
To view a schedule of current funding opportunities, please click here.
Please note that dates are subject to change. To be notified of all grant opportunities as their application period opens, sign up for email
OREF Total Joint Replacement Research Grant in Honor of Jorge O. Galante, MD
$300,000 over a three-year grant period
OREF thanks everyone who contributed to the Galante Mentor Campaign
for making this grant possible.
- OREF encourages investigator-initiated research proposals focused on total joint replacement. Areas of research focus may include: New surgical techniques, devices, joint implant designs, joint implant materials, or the biology of disease and repair.
- OREF strongly encourages the submission of well-crafted basic, translational and clinical studies.
- Clinical relevance must be clearly noted in the abstract and specific aims and be obvious from the title and the study design. All proposed projects should generate results that have a practical application. It is expected that upon completion of the proposed project, the principal investigator will be well poised to pursue NIH/DOD or the equivalent large-scale funding to continue to advance the area of research.
Letters of Intent (LOI)
- Domestic, non-profit, public, and private institutions of higher education, such as hospitals, medical schools, universities, and colleges.
- Multidisciplinary research activity is always encouraged. The principal investigator (PI) must be an orthopaedic surgeon or a full-time researcher (e.g., PhD, DVM, DO). The orthopaedic surgeon must be licensed to practice and working in an institution in the United States. A PhD serving as PI or co-PI must hold a primary or secondary faculty appointment in an orthopaedic department. A letter from the department chair confirming this appointment is required.
- The PI must be a new investigator. A new investigator is classified as an individual who has not received an R01 National Institutes of Health (NIH) grant or its equivalent (e.g., VA, DOD, NSF) as a PI.
—The first step in applying for this grant is to submit a Letter of Intent (LOI), following the instructions provided on proposalCENTRAL. All properly submitted LOIs will be reviewed by OREF. If your LOI is selected to advance, you will be invited to complete a full proposal.
The next RFA date for this grant is TBD.
Oct 16, 2019, 10:59 PM
Have a question for the OREF Grants team?
Submit a question here or email us at email@example.com.